ASCO Direct 2026 is a premier, licensed oncology educational program that brings the latest updates from the American Society of Clinical Oncology Annual Meeting directly to regional audiences. Designed for clinicians, researchers, and healthcare professionals, the program delivers expert-led insights into cutting-edge research, emerging therapies, and best practices in cancer care, enabling meaningful translation of global advancements into local clinical practice.

In 2026, India joins a select group of countries worldwide to host ASCO Direct, reinforcing its growing role in the global oncology ecosystem and providing Indian professionals with direct access to internationally relevant scientific knowledge